当前位置: X-MOL 学术J. Clin. Pharm. Ther. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Sustained adherence to ESC guideline-recommended medications is associated with lower long-term mortality in heart failure and reduced ejection fraction: Insights from the EPICAL2 cohort.
Journal of Clinical Pharmacy and Therapeutics ( IF 2 ) Pub Date : 2020-05-27 , DOI: 10.1111/jcpt.13176
Sarah Bitar 1, 2 , Nathalie Thilly 2, 3 , Nelly Agrinier 1, 2
Affiliation  

The real‐life prognostic impact on long‐term survival of continuous or discontinuous adherence to ESC guideline‐recommended drugs in heart failure with reduced ejection fraction (HFrEF) patients has rarely been investigated. Here, we present the long‐term association of longitudinal prescription of guideline‐recommended drugs with 3‐year all‐cause and cardiovascular (CV) mortality in HFrEF patients.

中文翻译:

持续遵循ESC指南推荐的药物可降低心力衰竭的长期死亡率并降低射血分数:EPICAL2研究组的见解。

很少研究连续或不连续遵守ESC指南推荐药物在射血分数降低(HFrEF)的心力衰竭患者中对长期生存的现实预后影响。在这里,我们介绍了指南性推荐药物的纵向处方与HFrEF患者的3年全因和心血管(CV)死亡率的长期关联。
更新日期:2020-07-06
down
wechat
bug